USE OF LADOSTIGIL FOR THE TREATMENT OF MULTIPLE SCLEROSIS
摘要
Disclosed are methods for the treatment of a form of multiple sclerosis comprising administering an amount of R(+) -6- (N-methyl, N- ethyl -carbamoyl oxy) -N' -propargyl-1- aminoindan or a pharmaceutically acceptable salt thereof .
申请公布号
WO2006130726(A3)
申请公布日期
2007.01.18
申请号
WO2006US21184
申请日期
2006.05.31
申请人
TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICALS USA, INC.;GOREN, TAMAR;BLAUGRUND, ERAN
